SANOFI-AVENTIS SA, SNY
Sanofi Aventis (NYSE: SNY) ended the last trading session at $28.90. So far the stock has hit a 52-week low of $23.95 and 52-week high of $37.11. Sanofi Aventis stock has been showing support around 28.33 and resistance in the 29.43 range. Technical indicators for the stock are Bearish and S&P gives SNY a positive 4 STAR (out of 5) buy rating. SNY appears on the Investors Observer Analysts Favorites list. For a hedged play on this stock, look at a Sep '09 27.50 covered call (SNY IY) for a net debit in the $26.35 area. That is also the break even stock price for this trade. This covered call has a 68 day duration, provides 8.82% downside protection and a 4.36% assigned return rate for a 23.43% annualized return rate (comparison purposes only). Sanofi Aventis has a current annual dividend yield of 3.61%.
ABOUT
Sanofi-Aventis, a pharmaceutical comany, contributes to enhancing life by providing an offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the
Last Trade: 4.55
Day's Range: 4.35 - 4.64
52wk Range: 2.36 - 7.87
Volume: 11,875,593
WhisperfromWallStreet.com has a proven track record in picking winning stocks. While neither we nor anyone can offer a guarantee, we scan countless stocks on a daily basis to seek out those that have the greatest opportunity for gain. When we find these stocks, we immediately send an alert to our membership. Please feel free to track our results by joining our newsletter free. So far in 2009 we have sent over 40 alerts to our members with an average gain of over 80%.
Join our stock alert service free.
If you're an investor and interested in knowing which penny stocks are getting ready to run, sign up for our penny alerts at http://whisperfromwallstreet.com/
During 2009 we have sent out over 40 stock alerts resulting in an over 80% price gain. Sign up now FREE to track our results.
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This press release should not be construed as a solicitation to buy or sell any particular stock or security. Neither WhisperfromWallstreet, nor any of its affiliates are registered investment advisors or broker dealers.
